The DHA, as functional excipient, was used to synthesize nanoparticles for reversing drug resistance in hepatocellular carcinoma (HCC) via suppressing drug-resistant proteins MRP, LRP, BCRP, and Bcl-2 (Wang et al., 2021a). This evidence concerns the gene ABCC1 and hepatocellular carcinoma.